A multicenter, open-label study to assess pharmacokinetics, efficacy, tolerability and safety of Rupatadine in paediatrics patients (2-5 years old) with allergic rhinitis.
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2011
At a glance
- Drugs Rupatadine (Primary)
- Indications Allergic rhinitis
- Focus Pharmacokinetics
- 21 Jun 2011 New trial record